These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2427577)

  • 1. Biosynthesis and glycosylation of the human complement regulatory protein decay-accelerating factor.
    Lublin DM; Krsek-Staples J; Pangburn MK; Atkinson JP
    J Immunol; 1986 Sep; 137(5):1629-35. PubMed ID: 2427577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthesis of the human C3b/C4b receptor during differentiation of the HL-60 cell line. Identification and characterization of a precursor molecule.
    Atkinson JP; Jones EA
    J Clin Invest; 1984 Nov; 74(5):1649-57. PubMed ID: 6334100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosynthesis and glycosylation of p150,95 and related leukocyte adhesion proteins.
    Miller LJ; Springer TA
    J Immunol; 1987 Aug; 139(3):842-7. PubMed ID: 3298434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The E3-20.5K membrane protein of subgroup B human adenoviruses contains O-linked and complex N-linked oligosaccharides.
    Hawkins LK; Wold WS
    Virology; 1995 Jul; 210(2):335-44. PubMed ID: 7618271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical characterization of membrane cofactor protein of the complement system.
    Ballard LL; Bora NS; Yu GH; Atkinson JP
    J Immunol; 1988 Dec; 141(11):3923-9. PubMed ID: 3053903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the xenoantigenicity of neonatal porcine islet-like cell clusters (NPCC) and the efficiency of adenovirus-mediated DAF (CD55) expression.
    Omori T; Nishida T; Komoda H; Fumimoto Y; Ito T; Sawa Y; Gao C; Nakatsu S; Shirakura R; Miyagawa S
    Xenotransplantation; 2006 Sep; 13(5):455-64. PubMed ID: 16925670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Glycosylation of the human kappa opioid receptor enhances its stability but slows its trafficking along the biosynthesis pathway.
    Li JG; Chen C; Liu-Chen LY
    Biochemistry; 2007 Sep; 46(38):10960-70. PubMed ID: 17711303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additional forms of human decay-accelerating factor (DAF).
    Seya T; Farries T; Nickells M; Atkinson JP
    J Immunol; 1987 Aug; 139(4):1260-7. PubMed ID: 2440950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthesis and glycosylation of the carcinoma-associated antigen recognized by monoclonal antibody KS1/4.
    Fernsten PD; Pekny KW; Reisfeld RA; Walker LE
    Cancer Res; 1990 Aug; 50(15):4656-63. PubMed ID: 1695123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Swainsonine induced modification of N-linked oligosaccharides on human phagocytic cell formyl peptide chemotactic receptors.
    Heiman DF; Malech HL
    Biomed Pharmacother; 1987; 41(6):278-84. PubMed ID: 2833322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland.
    Lass JH; Walter EI; Burris TE; Grossniklaus HE; Roat MI; Skelnik DL; Needham L; Singer M; Medof ME
    Invest Ophthalmol Vis Sci; 1990 Jun; 31(6):1136-48. PubMed ID: 1693916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular transport and processing of the Marburg virus surface protein in vertebrate and insect cells.
    Becker S; Klenk HD; Mühlberger E
    Virology; 1996 Nov; 225(1):145-55. PubMed ID: 8918541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosynthesis pathway of gp90MEL-14, the mouse lymph node-specific homing receptor.
    van de Rijn M; Weissman IL; Siegelman M
    J Immunol; 1990 Sep; 145(5):1477-82. PubMed ID: 2166761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of DAF-2, a high molecular weight form of decay-accelerating factor (DAF; CD55), as a covalently cross-linked dimer of DAF-1.
    Nickells MW; Alvarez JI; Lublin DM; Atkinson JP
    J Immunol; 1994 Jan; 152(2):676-85. PubMed ID: 7506731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biochemical characterization of E2, a T cell surface molecule involved in rosettes.
    Aubrit F; Gelin C; Pham D; Raynal B; Bernard A
    Eur J Immunol; 1989 Aug; 19(8):1431-6. PubMed ID: 2789140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for variations in the sensitivity of human decay accelerating factor to phosphatidylinositol-specific phospholipase C cleavage.
    Walter EI; Roberts WL; Rosenberry TL; Ratnoff WD; Medof ME
    J Immunol; 1990 Feb; 144(3):1030-6. PubMed ID: 1688588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthesis and shedding of epiglycanin: a mucin-type glycoprotein of the mouse TA3Ha mammary carcinoma cell.
    Thingstad T; Vos HL; Hilkens J
    Biochem J; 2001 Jan; 353(Pt 1):33-40. PubMed ID: 11115396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosynthetic and structural studies on Thy-1 in a rat neuronal tumor cell line.
    Wilkerson LS; Touster O
    Arch Biochem Biophys; 1993 Jun; 303(2):238-45. PubMed ID: 8099781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the oligosaccharides on the HLA-DR and DC1 B cell antigens.
    Shackelford DA; Strominger JL
    J Immunol; 1983 Jan; 130(1):274-82. PubMed ID: 6600184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoprotein nature of dopamine D1 receptors in the brain and parathyroid gland.
    Jarvie KR; Booth G; Brown EM; Niznik HB
    Mol Pharmacol; 1989 Oct; 36(4):566-74. PubMed ID: 2682204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.